ManagementNSE · INDOUS
Indo Us Biotech Limited
General Updates
01 / The disclosure
What the company shared
Indo Us Biotech Limited has informed the Exchange about General Updates_regarding Directors cum Promoters and other Promoter visit to China Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Exchange-provided summary Company profile
A question for your research
Check the role, effective date, stated reason and succession arrangements.
The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106826480
- First collected
- 23 Oct 2026, 16:31 IST
- PDF extraction
- metadata_only
You’ve reached the end of this disclosure.